nach oben

Cellular Oncology

Erschienen in:

14.12.2017 | Original Paper

Role of β-catenin in cisplatin resistance, relapse and prognosis of head and neck squamous cell carcinoma

verfasst von: Souvick Roy, Madhabananda Kar, Shomereeta Roy, Arka Saha, Swatishree Padhi, Birendranath Banerjee

Erschienen in: Cellular Oncology | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Head and neck squamous cell carcinoma (HNSCC) is one of the most common types of cancer in India with high incidence and rapid recurrence rates. Here, we aimed to investigate the role of β-catenin, a developmental pathway gene, in HNSCC therapy resistance, DNA damage response, recurrence and prognosis.

Methods

In total 80 HNSCC samples were included. Western blot, immunohistochemistry and qRT-PCR analyses were performed to assess β-catenin expression in the cut margin and tumor areas of each sample. Kaplan-Meier analyses were performed to correlate β-catenin expression with the survival and prognosis of HNSCC patients. In addition, chemo-resistance, DNA damage response and DNA repair capacities were evaluated in HNSCC-derived cell lines through LiCl-mediated up-regulation and siRNA-mediated silencing of β-catenin expression.

Results

We observed β-catenin up-regulation in cut margin areas of recurrent patients compared to their corresponding tumor regions, which subsequently could be associated with poor prognosis. In addition, we found that LiCl-mediated up-regulation of β-catenin in HNSCC-derived cells led to cisplatin resistance, evasion of apoptosis, enhanced DNA repair and enhanced migration. The effects of β-catenin silencing correlated with its putative role in chemo-resistance and DNA damage response.

Conclusion

From our results we conclude that β-catenin may contribute to HNSCC therapy resistance and disease relapse. As such, β-catenin may be explored as a therapeutic target along with conventional therapeutics.

Nur mit Berechtigung zugänglich

S. Padhi, A. Saha, M. Kar, C. Ghosh, A. Adhya, M. Baisakh, N. Mohapatra, S. Venkatesan, M.P. Hande, B. Banerjee, Clinico-pathological correlation of β-catenin and telomere dysfunction in head and neck squamous cell carcinoma patients. J Cancer 6, 192–202 (2015). https://doi.org/10.7150/jca.9558 CrossRefPubMedPubMedCentral

P. Joshi, S. Dutta, P. Chaturvedi, S. Nair, Head and neck cancers in developing countries. Rambam Maimonides Med J 5, e0009 (2014). https://doi.org/10.5041/rmmj.10143 CrossRefPubMedPubMedCentral

E.M. Smith, L.M. Rubenstein, T.H. Haugen, E. Hamsikova, L.P. Turek, Tobacco and alcohol use increases the risk of both HPV-associated and HPV-independent head and neck cancers. Cancer Causes Control: CCC 21, 1369–1378 (2010). https://doi.org/10.1007/s10552-010-9564-z CrossRefPubMed

S. Vishak, B. Rangarajan, V.D. Kekatpure, Neoadjuvant chemotherapy in oral cancers: Selecting the right patients. Indian J Med Paediatr 36, 148–153 (2015). https://doi.org/10.4103/0971–5851.166716 CrossRef

S. Ghuwalewala, D. Ghatak, P. Das, S. Dey, S. Sarkar, N. Alam, C.K. Panda, S. Roychoudhury, CD44(high)CD24(low) molecular signature determines the Cancer Stem Cell and EMT phenotype in Oral Squamous Cell Carcinoma. Stem Cell Res 16, 405–417 (2016). https://doi.org/10.1016/j.scr.2016.02.028 CrossRefPubMed

M. Bruggemann, C. Pott, M. Ritgen, M. Kneba, Significance of minimal residual disease in lymphoid malignancies. Acta Haematol 112, 111–119 (2004). https://doi.org/10.1159/000077566 CrossRefPubMed

S. Bhattacharyya, V. Sekar, B. Majumder, D.G. Mehrotra, S. Banerjee, A.K. Bhowmick, N. Alam, G.K. Mandal, J. Biswas, P.K. Majumder, N. Murmu, CDKN2A-p53 mediated antitumor effect of Lupeol in head and neck cancer. Cell Oncol 40, 145–155 (2017). https://doi.org/10.1007/s13402-016-0311-7 CrossRef

I.P. Ribeiro, F. Caramelo, F. Marques, A. Domingues, M. Mesquita, L. Barroso, H. Prazeres, M.J. Juliao, I.P. Baptista, A. Ferreira, J.B. Melo, I.M. Carreira, WT1, MSH6, GATA5 and PAX5 as epigenetic oral squamous cell carcinoma biomarkers - a short report. Cell Oncol 39, 573–582 (2016). https://doi.org/10.1007/s13402-016-0293-5 CrossRef

L. Kadletz, G. Heiduschka, R. Wiebringhaus, E. Gurnhofer, U. Kotowski, G. Haymerle, M. Brunner, C. Barry, L. Kenner, ELMO3 expression indicates a poor prognosis in head and neck squamous cell carcinoma - a short report. Cell Oncol 40, 193–198 (2017). https://doi.org/10.1007/s13402-016-0310-8 CrossRef

10.

H. Zahreddine, K.L. Borden, Mechanisms and insights into drug resistance in cancer. Front Pharmacol 4, 28 (2013). https://doi.org/10.3389/fphar.2013.00028 CrossRefPubMedPubMedCentral

11.

K.Q. Liu, Z.P. Liu, J.K. Hao, L. Chen, X.M. Zhao, Identifying dysregulated pathways in cancers from pathway interaction networks. BMC Bioinf 13, 126 (2012). https://doi.org/10.1186/1471–2105–13-126 CrossRef

12.

E.M.F. de Sousa, L. Vermeulen, Wnt signaling in cancer stem cell biology. Cancers 8 (2016). doi: https://doi.org/10.3390/cancers8070060

13.

S. Dasari, P.B. Tchounwou, Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol 740, 364–378 (2014). https://doi.org/10.1016/j.ejphar.2014.07.025 CrossRefPubMed

14.

D.J. Stewart, Wnt signaling pathway in non-small cell lung cancer. J Natl Cancer Inst 106, djt356 (2014). https://doi.org/10.1093/jnci/djt356 CrossRefPubMed

15.

J. Zhang, J. Liu, H. Li, J. Wang, β-catenin signaling pathway regulates cisplatin resistance in lung adenocarcinoma cells by upregulating Bcl-xl. Mol Med Rep 13, 2543–2551 (2016). https://doi.org/10.3892/mmr.2016.4882 CrossRefPubMedPubMedCentral

16.

M. Kabatkova, O. Zapletal, Z. Tylichova, J. Neca, M. Machala, A. Milcova, J. Topinka, A. Kozubik, J. Vondracek, Inhibition of beta-catenin signalling promotes DNA damage elicited by benzo[a]pyrene in a model of human colon cancer cells via CYP1 deregulation. Mutagenesis 30, 565–576 (2015). https://doi.org/10.1093/mutage/gev019 CrossRefPubMed

17.

A. Saha, S. Padhi, M. Kar, S. Roy, P. Maiti, B. Banerjee, Role of TRF2 in efficient DNA repair, spheroid formation and cancer stem cell maintenance. Oncomedicine 2, 71–79 (2017). https://doi.org/10.7150/oncm.18373

18.

A. Saha, S. Shree Padhi, S. Roy, B. Banerjee, Method of detecting new cancer stem cell-like enrichment in development front assay (DFA). J Stem Cells 9, 235–242 (2014)PubMed

19.

A. Saha, S. Shree Padhi, S. Roy, B. Banerjee, HCT116 colonospheres shows elevated expression of hTERT and beta-catenin protein - a short report. J Stem Cells 9, 243–251 (2014)PubMed

20.

J.P. Newman, B. Banerjee, W. Fang, A. Poonepalli, L. Balakrishnan, G.K. Low, R.N. Bhattacharjee, S. Akira, M. Jayapal, A.J. Melendez, R. Baskar, H.W. Lee, M.P. Hande, Short dysfunctional telomeres impair the repair of arsenite-induced oxidative damage in mouse cells. J Cell Physiol 214, 796–809 (2008). https://doi.org/10.1002/jcp.21276 CrossRefPubMed

21.

B.M. Gyori, G. Venkatachalam, P.S. Thiagarajan, D. Hsu, M.V. Clement, OpenComet: an automated tool for comet assay image analysis. Redox Biol 2, 457–465 (2014). https://doi.org/10.1016/j.redox.2013.12.020 CrossRefPubMedPubMedCentral

22.

D.R. Rhodes, S. Kalyana-Sundaram, V. Mahavisno, R. Varambally, J. Yu, B.B. Briggs, T.R. Barrette, M.J. Anstet, C. Kincead-Beal, P. Kulkarni, S. Varambally, D. Ghosh, A.M. Chinnaiyan, Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 9, 166–180 (2007). https://doi.org/10.1593/neo.07112 CrossRefPubMedPubMedCentral

23.

M.A. Ginos, G.P. Page, B.S. Michalowicz, K.J. Patel, S.E. Volker, S.E. Pambuccian, F.G. Ondrey, G.L. Adams, P.M. Gaffney, Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res 64, 55–63 (2004). https://doi.org/10.1158/0008-5472.CAN-03-2144 CrossRefPubMed

24.

C.H. Peng, C.T. Liao, S.C. Peng, Y.J. Chen, A.J. Cheng, J.L. Juang, C.Y. Tsai, T.C. Chen, Y.J. Chuang, C.Y. Tang, W.P. Hsieh, T.C. Yen, A novel molecular signature identified by systems genetics approach predicts prognosis in oral squamous cell carcinoma. PloS one 6, e23452 (2011). https://doi.org/10.1371/journal.pone.0023452 CrossRefPubMedPubMedCentral

25.

A. Cromer, A. Carles, R. Millon, G. Ganguli, F. Chalmel, F. Lemaire, J. Young, D. Dembele, C. Thibault, D. Muller, O. Poch, J. Abecassis, B. Wasylyk, Dentification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis. Oncogene 23, 2484–2498 (2004). https://doi.org/10.1038/sj.onc.1207345 CrossRefPubMed

26.

S. Sekine, T. Shibata, M. Sakamoto, S. Hirohashi, Target disruption of the mutant β-catenin gene in colon cancer cell line HCT116: preservation of its malignant phenotype. Oncogene 21, 5906–5911 (2002). https://doi.org/10.1038/sj.onc.1205756 CrossRefPubMed

27.

A.B. Sparks, P.J. Morin, B. Vogelstein, K.W. Kinzler, Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 58, 1130–1134 (1998)PubMed

28.

E. Beurel, M. Kornprobst, M.J. Blivet-Van Eggelpoel, C. Ruiz-Ruiz, A. Cadoret, J. Capeau, C. Desbois-Mouthon, GSK-3beta inhibition by lithium confers resistance to chemotherapy-induced apoptosis through the repression of CD95 (Fas/APO-1) expression. Exp Cell Res 300, 354–364 (2004). https://doi.org/10.1016/j.yexcr.2004.08.001 CrossRefPubMed

29.

S.G. Shiah, Y.S. Shieh, J.Y. Chang, The Role of Wnt Signaling in Squamous Cell Carcinoma. J Dent Res 95, 129–134 (2016). https://doi.org/10.1177/0022034515613507 CrossRefPubMed

30.

Padhi SS, Kar M, Saha A, Baisakh MR, Mohapatra N, Banerjee BN. Rapid recurrence and poor prognosis with altered levels of β-catenin in 3 cases of head and neck squamous cell carcinoma patients. Head Neck Oncol 6, 39 (2014)

31.

Y. Yamano, K. Uzawa, K. Saito, D. Nakashima, A. Kasamatsu, H. Koike, Y. Kouzu, K. Shinozuka, K. Nakatani, K. Negoro, S. Fujita, H. Tanzawa, Identification of cisplatin-resistance related genes in head and neck squamous cell carcinoma. Int J Cancer 126, 437–449 (2010). https://doi.org/10.1002/ijc.24704 CrossRefPubMed

32.

D.W. Shen, L.M. Pouliot, M.D. Hall, M.M. Gottesman, Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes. Pharmacol Rev 64, 706–721 (2012). https://doi.org/10.1124/pr.111.005637 CrossRefPubMedPubMedCentral

33.

M.K. Mohammed, C. Shao, J. Wang, Q. Wei, X. Wang, Z. Collier, S. Tang, H. Liu, F. Zhang, J. Huang, D. Guo, M. Lu, F. Liu, J. Liu, C. Ma, L.L. Shi, A. Athiviraham, T.C. He, M.J. Lee, Wnt/beta-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance. Genes Dis 3, 11–40 (2016). https://doi.org/10.1016/j.gendis.2015.12.004 CrossRefPubMedPubMedCentral

34.

N. Kneidinger, A.O. Yildirim, J. Callegari, S. Takenaka, M.M. Stein, R. Dumitrascu, A. Bohla, K.R. Bracke, R.E. Morty, G.G. Brusselle, R.T. Schermuly, O. Eickelberg, M. Konigshoff, Activation of the WNT/beta-catenin pathway attenuates experimental emphysema. Am. J. Respir. Crit. Care Med. 183, 723–733 (2011). https://doi.org/10.1164/rccm.200910-1560OC CrossRefPubMed

35.

A.M. Florea, D. Busselberg, Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects. Cancers 3, 1351–1371 (2011). https://doi.org/10.3390/cancers3011351 CrossRefPubMedPubMedCentral

36.

A. Basu, S. Krishnamurthy, Cellular responses to Cisplatin-induced DNA damage. J Nucleic Acids 2010, 1–16 (2010). https://doi.org/10.4061/2010/201367

37.

R.W. Robey, O. Polgar, J. Deeken, K.W. To, S.E. Bates, BCG2: determining its relevance in clinical drug resistance. Cancer Metastasis Rev 26, 39–57 (2007). https://doi.org/10.1007/s10555-007-9042-6 CrossRefPubMed

Titel: Role of β-catenin in cisplatin resistance, relapse and prognosis of head and neck squamous cell carcinoma
verfasst von: Souvick Roy
Madhabananda Kar
Shomereeta Roy
Arka Saha
Swatishree Padhi
Birendranath Banerjee
Publikationsdatum: 14.12.2017
Verlag: Springer Netherlands
Erschienen in: Cellular Oncology / Ausgabe 2/2018
Print ISSN: 2211-3428
Elektronische ISSN: 2211-3436
DOI: https://doi.org/10.1007/s13402-017-0365-1

Neu im Fachgebiet Pathologie

Open Access 15.04.2024 | Biomarker | Schwerpunkt: Next Generation Pathology

Springer Medizin

Role of β-catenin in cisplatin resistance, relapse and prognosis of head and neck squamous cell carcinoma

Abstract

Background

Methods

Results

Conclusion

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Personalisierte Medizin in der Onkologie

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2018

Expression and function of immune ligand-receptor pairs in NK cells and cancer stem cells: therapeutic implications

Organ-specific metastasis of breast cancer: molecular and cellular mechanisms underlying lung metastasis

p53 expression and subcellular survivin localization improve the diagnosis and prognosis of patients with diffuse astrocytic tumors

Synergistic anticancer effect of panobinostat and topoisomerase inhibitors through ROS generation and intrinsic apoptotic pathway induction in cervical cancer cells

Role of Glypican-3 in the growth, migration and invasion of primary hepatocytes isolated from patients with hepatocellular carcinoma

Establishing cut-off points with clinical relevance for bcl-2, cyclin D1, p16, p21, p27, p53, Sox11 and WT1 expression in glioblastoma - a short report

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Personalisierte Medizin in der Onkologie